2m 2m 2m 2m 2m 2m 2m
AQUESTIVE THERP (AQST)
NASDAQ
$4.13-$0.005 (-0.12%)
Price as of Oct 22, 2026 7:40 PM EDT- $512.1MMarket Cap
- -40.35%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AQUESTIVE THERP (AQST)
$4.13-$0.005 (-0.12%)
AQST | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.13 | ||
Change | +$0.03 (+0.74%) | ||
Open | $4.10 | ||
High | $4.16 | ||
Low | $4.04 | ||
Previous Close | $4.08 | ||
Volume | 1,853,118 | ||
30-Day Average Volume | 2,247,204 | ||
1-Week Change | -11.50% | ||
1-Month Change | -14.64% | ||
1-Year Change | -40.35% | ||
3-Year Change | 164.94% | ||
5-Year Change | -8.72% | ||
Fundamentals | |||
Shares Outstanding | 125.5M | ||
Total Assets | $132.1M | ||
Market Cap | $512.1M | ||
Enterprise Value | $464.3M | ||
Period: QTR TTM FY | |||
Revenue | $13.8M | ||
Net Income | -$22.9M | ||
Free Cash Flow | -$9.7M | ||
EBIT | -$22.9M | ||
EBITDA | -$22.7M | ||
Net Working Capital | $102.0M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -20 | ||
Enterprise Value/Revenue | 34 | ||
P/B | -9 | ||
P/E | -23 | ||
PEG | 0 | ||
Price/Free Cash Flow | -53 | ||
Price/Operating Cash Flow | -54 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue